Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110862396A details a novel Pd-catalyzed synthesis for pyrrolo[3,4-c]carbazole-1,3-diones. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Novel iodine-catalyzed oxidative sulfonylation method for high-purity pharmaceutical intermediates with reduced costs and scalable production capabilities.
Patent CN101863954B details a high-yield route for Finasteride intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for complex steroids.
Advanced synthesis of L-menthyl glyoxylate via patent CN102516078A. Offers high purity, improved yield, and cost reduction in API manufacturing for global supply chains.
Patent CN116396299A reveals a safer 7-step synthesis for Upadacitinib intermediates, offering high purity and significant cost reduction potential for pharmaceutical manufacturers.
Novel one-pot AgOTf catalyzed cyclization for pyrazolo[5,1-a]isoquinolines. High yield up to 90%, mild conditions, scalable for API intermediates.
Discover the advanced synthesis of N-substituted-3-(benzenesulfonyl)quinoxaline-2-amines via patent CN101602737B, offering cost-effective routes for oncology drug development.
Novel low-temperature catalytic route for D-penicillamine enhances yield and purity. Ideal for pharmaceutical intermediate suppliers seeking cost reduction and scalable production solutions.
Patent CN113461617A reveals a metal-free visible light method for N-heterocycles. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN1440374A details a high-yield route for renin inhibitors. Offers scalable chiral synthesis for pharma intermediates with superior purity.
Patent CN107021884A reveals high-efficiency Ir/f-amphox catalysis for chiral 1,2-amino alcohols, offering superior TON and enantioselectivity for pharmaceutical manufacturing.
Patent CN117447359B details a novel method for high-purity peramivir intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106986799A reveals high-yield Cu-Ni catalysis for aryl sulfides. Enables cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN110128288B reveals a safe cyanide-free route for amino-substituted cyclopentane derivatives, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN115894364A reveals a green water-based photocatalytic route for alkynyl tetrahydroisoquinoline derivatives, offering significant supply chain and cost advantages.
Patent CN112608970A reveals water-based biotransformation for methylprednisolone. Enhances conversion rates and supply chain reliability for pharmaceutical intermediates.
Patent CN101760495B reveals a bio-dehydrogenation method for steroid intermediates. Achieve higher yields and eliminate toxic selenium residues for cost-effective manufacturing.
Advanced steroid intermediate synthesis via patent CN106893752A. Delivers high purity, reduced heavy metals, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN103265426A details an eco-friendly method for 2-(4-bromomethylphenyl)propionic acid, utilizing aqueous-organic biphasic systems to enhance atom economy and reduce hazardous emissions.
Patent CN106520896B reveals one-step fermentation for 8DM. Enhances yield and reduces solvent use for reliable pharmaceutical intermediates supply chains.